Lu, Pin

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Kadri, S., Lee, J., Fitzpatrick, C., Galanina, N., Sukhanova, M., Venkataraman, G., Sharma, S., Long, B., Petras, K., Theissen, M., et al. (2017) · Blood Advances

Chronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia Research

Cited by 133

Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells

Ma, J., Lu, P., Guo, A., Cheng, S., Zong, H., Martin, P., Coleman, M., & Wang, Y. L. (2014) · British Journal of Haematology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 90

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL

Sharma, S., Galanina, N., Guo, A., Lee, J., Kadri, S., Van Slambrouck, C., Long, B., Wang, W., Ming, M., Furtado, L. V., et al. (2016) · Oncotarget

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 90

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Song, Z., Lu, P., Furman, R. R., Leonard, J. P., Martin, P., Tyrell, L., Lee, F. Y., Knowles, D. M., Coleman, M., & Wang, Y. L. (2010) · Clinical Cancer Research

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 59

Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

Guo, A., Lu, P., Coffey, G., Conley, P., Pandey, A., & Wang, Y. L. (2017) · Oncotarget

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 52